LABCORP HOLDINGS INC.
Company Stats
- Market Cap
- $25.0B
- as of Sep 30, 2026
- Shares Outstanding
- 81.1M
- Free Float
- 94.6%
Income Statement
- Revenue
- $14.0B
- Operating Income
- $1.4B
- Net Income
- $876.5M
- EBITDA
- $2.1B
- Non-cash Impairment
- $4.3M
- Revenue Growth, 3Y
- 5.6%
- FCF Margin, 3Y Avg
- 8.1%
- FCF Margin, Worst Year
- 7.2%
Cash Flow
- Free Cash Flow
- $1.2B
- FCF Yield
- 4.8%
- Owner FCF Yield
- 4.3%
Balance Sheet
- Cash & Equivalents
- $532.3M
Returns & Capital
- Dividends Paid
- $240.7M
- Dividend Yield
- 1.0%
- Dividend Payout, 3Y Avg
- 40.3%
- Share Repurchases
- $450.0M
- Buyback Yield, 3Y Avg
- 2.3%
- SBC, 3Y Avg
- $123.7M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $14.0B | $1.2B | 8.6% |
| FY2024 | $13.0B | $1.1B | 8.4% |
| FY2023 | $12.2B | $874.1M | 7.2% |
| FY2022 | $11.9B | $1.5B | 12.9% |
| FY2021 | $13.1B | $2.7B | 20.5% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 16, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Labcorp to Buy Myriad Prenatal Health Unit for $210 Million in Cash Plus Inventory Value at Closing
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back